Diorcinol D
Diorcinol D is a natural product with antifungal activity. Diorcinol D inhibits CYP51 expression, reduces Cdr1 expression, blocks efflux pump activity, and impedes ergosterol biosynthesis. It inhibits planktonic and biofilm growth of Candida albicans. Diorcinol D is applicable to research related to fungal infections.
For research use only. We do not sell to patients.
- CAS No.: 1464778-45-7
- Formula: C19H22O3
- Molecular Weight:298.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vitro
Diorcinol D inhibits planktonic growth of wild-type, Fluconazole (HY-B0101)-sensitive, Fluconazole-resistant and efflux pump-mutant Candida albicans strains, with an MIC range of 6 μg/mL to 16 μg/mL. Notably, the CDR1-deficient mutant shows increased sensitivity (MIC = 6 μg/mL)[1].
Diorcinol D (24 h) inhibits the growth of mature biofilms formed by wild-type, fluconazole-sensitive and fluconazole-resistant Candida albicans strains, with an MIC of 32 μg/mL[1].
Diorcinol D (8-32 μg/mL; 48 h) significantly increases cell death in mature Candida albicans YEM30 biofilms at the concentration of 32 μg/mL[1].
Diorcinol D (4-12 μg/mL; 30 min) dose-dependently inhibits ATP-driven Rh123 efflux in both fluconazole-sensitive Candida albicans strain 18B and fluconazole-resistant strain 28I[1].
Diorcinol D (4-12 μg/mL; 3 h) reduces the expression of CDR1 in Candida albicans CASA1 in a dose-dependent manner[1].
Diorcinol D (4-12 μg/mL; 3 h) dose-dependently reduces ergosterol biosynthesis in Fluconazole-susceptible Candida albicans strain 18B and Fluconazole-resistant strain 28I, with a reduction range of 6.1% to 37.2%[1].
Diorcinol D (8 μg/mL; 3 h) reduces the CYP51 gene expression level by 2.8-fold in Fluconazole-susceptible Candida albicans strain 18B, and by 1.8-fold in Fluconazole-resistant Candida albicans strain 28I[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Candida albicans CASA1
-
Concentration:4, 8, and 12 μg/mL
-
Incubation Time:3 h
-
Result:Significant decreaseD in GFP fluorescence.
Chemical Information
-
CAS No. 1464778-45-7
-
Molecular Weight 298.38
-
Formula C19H22O3
-
SMILES
CC1=CC(OC2=CC(O)=CC(C)=C2C/C=C(C)/C)=CC(O)=C1
-
Structure Classification
-
Initial Source
endophytic fungus
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Fungal Biofilm Culture
Fungal biofilm culture is an in vitro method for growing surface-attached fungal communities, most commonly Candida albicans, on abiotic substrates such as polystyrene wells, silicone elastomer, or polymethylmethacrylate; the assay models adhesion, proliferation, filamentation, extracellular-matrix-associated maturation, and dispersion. Biofilm output can be read by optical density at 600 nm for adherent biomass, XTT reduction for metabolic activity, CFU recovery for viable attached or dispersed cells, and microscopy for architecture.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Diorcinol D Related Classifications
HY-N19799 Related Classifications
Powered by Bioz